A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I

Henry Eriksson, Karin Wåhlander, David Gustafsson, Lennart Welin, Lars Frison, Sam Schulman

Journal of Thrombosis and Haemostasis · 2003 · 165 citations · 27 references

DOIFull text

Open access

Concepts

References

27